On June 7th, Glon Hui reported that Shanxi C&Y Pharmaceutical Group (300254.SZ) received a special fund totaling 4 million yuan for the consistency evaluation award of the generic salt succinate tablets for technical renovation in 2024 from the Finance Bureau of Datong Economic and Technological Development Zone.
仟源医药(300254.SZ)：获得政府补助400万元
Shanxi C&Y Pharmaceutical Group (300254.SZ) received a government subsidy of RMB 4 million.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.